19-54573909-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001130917.3(LILRA2):​c.31C>T​(p.Leu11Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00017 in 1,614,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 40)
Exomes 𝑓: 0.00018 ( 0 hom. )

Consequence

LILRA2
NM_001130917.3 missense

Scores

3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.17
Variant links:
Genes affected
LILRA2 (HGNC:6603): (leukocyte immunoglobulin like receptor A2) This gene encodes a member of a family of immunoreceptors that are expressed predominantly on monocytes and B cells, and at lower levels on dendritic cells and natural killer cells. The encoded protein is an activating receptor that inhibits dendritic cell differentiation and antigen presentation and suppresses innate immune response. Alternatively spliced transcript variants encoding different isoforms have been found. This gene is located in a cluster of related genes on chromosome 19 and there is a pseudogene for this gene on chromosome 3. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12164682).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LILRA2NM_001130917.3 linkuse as main transcriptc.31C>T p.Leu11Phe missense_variant 1/8 ENST00000391738.8 NP_001124389.2 Q8N149-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LILRA2ENST00000391738.8 linkuse as main transcriptc.31C>T p.Leu11Phe missense_variant 1/81 NM_001130917.3 ENSP00000375618.3 Q8N149-1

Frequencies

GnomAD3 genomes
AF:
0.0000788
AC:
12
AN:
152256
Hom.:
0
Cov.:
40
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000677
AC:
17
AN:
251278
Hom.:
0
AF XY:
0.0000663
AC XY:
9
AN XY:
135786
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000180
AC:
263
AN:
1461838
Hom.:
0
Cov.:
158
AF XY:
0.000182
AC XY:
132
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000219
Gnomad4 OTH exome
AF:
0.000315
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152256
Hom.:
0
Cov.:
40
AF XY:
0.0000538
AC XY:
4
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000162
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000166
Hom.:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.0000741
AC:
9
EpiCase
AF:
0.000327
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 10, 2021The c.31C>T (p.L11F) alteration is located in exon 1 (coding exon 1) of the LILRA2 gene. This alteration results from a C to T substitution at nucleotide position 31, causing the leucine (L) at amino acid position 11 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
5.5
DANN
Uncertain
0.99
DEOGEN2
Benign
0.092
T;.;.;.;.;T
Eigen
Benign
-0.86
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.024
N
LIST_S2
Benign
0.66
T;.;.;.;T;.
M_CAP
Benign
0.0015
T
MetaRNN
Benign
0.12
T;T;T;T;T;T
MetaSVM
Benign
-0.75
T
PROVEAN
Uncertain
-3.0
D;D;D;D;D;.
REVEL
Benign
0.051
Sift
Benign
0.069
T;T;T;T;T;.
Sift4G
Uncertain
0.057
T;T;T;T;T;T
Polyphen
0.55
P;.;.;.;B;.
Vest4
0.17, 0.18, 0.11, 0.22
MVP
0.10
MPC
0.12
ClinPred
0.18
T
GERP RS
-1.1
gMVP
0.081

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139672047; hg19: chr19-55085376; API